Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: time to consider a more effective approach

被引：0
作者：
Moriya, Kei [1 ,2 ,3 ,4 ]
Nagamatsu, Shinsaku [1 ,2 ]
Uejima, Masakazu [1 ,2 ]
Matsuo, Hideki [1 ,2 ]
机构：
[1] Nara Prefecture Gen Med Ctr, Dept Gastroenterol, Nara, Japan
[2] Nara Med Univ, Dept Gastroenterol & Hepatol, Kashihara, Japan
[3] Nara Prefecture Gen Med Ctr, Dept Gastroenterol, 897-5,2 Chome,Shichijo Nishimachi, Nara 6308581, Japan
[4] Nara Med Univ, Dept Gastroenterol & Hepatol, 840 Shijo Cho, Kashihara, Japan
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2023年 / 14卷 / 05期
关键词：
Hepatocellular carcinoma (HCC); hepatic arterial infusion chemotherapy (HAIC); molecular targeted agents; immune checkpoint inhibitor (ICI); macrovascular invasion;
D O I：
10.21037/jgo-23-760
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2282 / 2286
页数：5
相关论文
共 25 条
[1]   Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis [J].
Chen, Xin-Long ;
Yu, Hai-Chuan ;
Fan, Qi-Gang ;
Yuan, Qi ;
Jiang, Wen-Kai ;
Rui, Shao-Zhen ;
Zhou, Wen-Ce .
ONCOLOGY LETTERS, 2022, 24 (04)
[2]  
Chinese Society of Clinical Oncology (CSCO), 2020, GUID HEP CARC VERS 2
[3]   Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis [J].
Fu, Yizhen ;
Peng, Wei ;
Zhang, Weixiang ;
Yang, Zhenyun ;
Hu, Zili ;
Pang, Yanxun ;
Hu, Dandan ;
Chen, Jinbin ;
Wang, Juncheng ;
Zhou, Zhongguo ;
Xu, Li ;
Chen, Minshan ;
Zhang, Yaojun .
JOURNAL OF GASTROENTEROLOGY, 2023, 58 (04) :413-424
[4]   Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma [J].
Gon, Hidetoshi ;
Kido, Masahiro ;
Tanaka, Motofumi ;
Kinoshita, Hisoka ;
Komatsu, Shohei ;
Tsugawa, Daisuke ;
Awazu, Masahide ;
Toyama, Hirochika ;
Matsumoto, Ippei ;
Itoh, Tomoo ;
Fukumoto, Takumi .
SURGERY, 2018, 164 (05) :1014-1022
[5]   Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study [J].
Gou, Qing ;
Wu, Lingeng ;
Cui, Wei ;
Mo, Zhiqiang ;
Zeng, Dejin ;
Gan, Liming ;
He, Jian ;
Mai, Qicong ;
Shi, Feng ;
Chen, Meng ;
Sun, Zhonghai ;
Liu, Yongdong ;
Wu, Jingjing ;
Chen, Xiumei ;
Zhuang, Wenhang ;
Xu, Rongde ;
Li, Weike ;
Cai, Qichun ;
Zhang, Jing ;
Chen, Xiaoming ;
Li, Jiaping ;
Zhou, Zejian .
EUROPEAN RADIOLOGY, 2021, 31 (08) :5851-5862
[6]  
Gu YK, 2022, J CLIN ONCOL, V40
[7]   Cisplatin in Liver Cancer Therapy [J].
Hamaya, Sae ;
Oura, Kyoko ;
Morishita, Asahiro ;
Masaki, Tsutomu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
[8]   Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial [J].
He, MinKe ;
Li, QiJiong ;
Zou, RuHai ;
Shen, JingXian ;
Fang, WanQiang ;
Tan, GuoSheng ;
Zhou, YuanMin ;
Wu, XiaoPing ;
Xu, Li ;
Wei, Wei ;
Le, Yong ;
Zhou, ZhongGuo ;
Zhao, Ming ;
Guo, Ying ;
Guo, RongPing ;
Chen, MinShan ;
Shi, Ming .
JAMA ONCOLOGY, 2019, 5 (07) :953-960
[9]   MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis [J].
Hong, Seung Baek ;
Choi, Sang Hyun ;
Kim, So Yeon ;
Shim, Ju Hyun ;
Lee, Seung Soo ;
Byun, Jae Ho ;
Park, Seong Ho ;
Kim, Kyung Won ;
Kim, Suk ;
Lee, Nam Kyung .
LIVER CANCER, 2021, 10 (02) :94-106
[10]   Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort Study [J].
Ishii, Masatsugu ;
Itano, Osamu ;
Iwamoto, Hideki ;
Hibi, Taizo ;
Itano, Satoshi .
ONCOLOGY, 2022, 100 (05) :278-289
123